'Resistant hypertension' diaporamas de présentation

TREATMENT of HYPERTENSION in the 21 st Century Sir George Pickering Lecture Peter Sever

1.32k views • 96 slides

Treatment of arterial hypertension in 20 10

725 views • 53 slides

CLINICAL APPROACH TO HYPERTENSION

887 views • 52 slides

Resistant Hypertension

721 views • 45 slides

ANTI-ALDOSTERONE DRUGS: WILL CINDERELLA BECOME A SUPERSTAR?

ANTI-ALDOSTERONE DRUGS: WILL CINDERELLA BECOME A SUPERSTAR?. Maria Rosa Costanzo, M.D. Medical Director, Midwest Heart Specialists Heart Failure Program Medical Director, Edward Hospital Center for Advanced Heart Failure Naperville, Illinois U.S.A. The Renin Angiotensin Aldosterone System.

594 views • 35 slides

688 views • 34 slides

AHA 2008 Resistant Hypertension: Diagnosis, Evaluation, and Treatment Slide Set

AHA 2008 Resistant Hypertension: Diagnosis, Evaluation, and Treatment Slide Set. Based on the AHA 2008 Scientific Statement Resistant Hypertension: Diagnosis, Evaluation, and Treatment. David A. Calhoun, MD, FAHA Vascular Biology and Hypertension Program University of Alabama at Birmingham.

309 views • 28 slides

Blood Pressure measurement

5.9k views • 27 slides

389 views • 26 slides

Primary Aldosteronism

Primary Aldosteronism. Paul S. Kellerman, M.D., FACP Associate Professor Division of Nephrology. 65,000,000, 31% of adults (1999-2000) (Fields et al, Hypertension, October 2004). EPIDEMIOLOGY OF HYPERTENSION. U.S. PREVALENCE 50,000,000, 27% of adults (1988-94)

1.32k views • 26 slides

RESISTANT HYPERTENSION

RESISTANT HYPERTENSION. What is it and How to Treat? Robert J Herman, MD FRCPC University of Calgary. Disclosures. None. Learning Objectives. Know the definition of resistant hypertension Have an approach to the work up and effective treatment of a patient with resistant hypertension

747 views • 26 slides

Disclosures for Dr. Bhatt

Renal Denervation in Patients with Uncontrolled Hypertension: Results of the SYMPLICITY HTN 3 Trial.

346 views • 24 slides

Resistant Hypertension

Resistant Hypertension. Outline. Definition Prevalence Risk Factors Secondary / Identifiable Causes HTN Elaboration on primary aldosteronism Treatment Assessing accurately Evaluate lifestyle factors Minimize interfering drugs If appropriate, screen for secondary causes Medications.

455 views • 18 slides

Leading causes of death worldwide (1990)

The epidemiology of hypertension and current treatment challenges Francesco P Cappuccio FRCP FFPH FAHA Professor of Cardiovascular Medicine & Epidemiology Consultant Physician Warwick Medical School and UHCW NHS Trust Coventry. Leading causes of death worldwide (1990). Chronic. Communicable.

389 views • 17 slides

Advances in medicine causes new, groundbreaking drug by Quantum Genomics (QNNTF) to help with chronic hypertension

Based in Paris and New York, Quantum Genomics trades on the OTCQX in the United States (symbol: QNNTF) and Euronext Paris (symbol: ALQGC). For more details visit: http://www.quantum-genomics.com/

92 views • 9 slides

journal of cardiology

Archives of Clinical Gastroenterology is an international, open access, peer-reviewed Journal, dedicated to the clinical and investigative studies, treatments, new diagnostic techniques, and other topics relating to the prevention, diagnosis, and treatment of disorders of the Gastroenteric system.

99 views • 6 slides

222 views • 5 slides

Advances in medicine causes new, groundbreaking drug by Quantum Genomics (QNNTF) to help with the chronic hypertension

Quantum Genomics are the creators of Firibastat, a first in class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin system. For details visit: http://www.quantum-genomics.com/

27 views • 2 slides

Primary outcome (%)

Cumulative incidence of primary endpoint with intensive vs. standard lipid-lowering in treatment-resistant hypertension. Atorvastatine 10 mg. 30. Atorvastatine 80 mg.

127 views • 1 slides

XXXIII Congreso SEMI-11th Congress EFIM RV - 117

136 views • 1 slides